References
- Stratton MR. Exploring the genomes of cancer cells: progress and promise. Science331(6024), 1553–1558 (2011).
- Roychowdhury S, Iyer MK, Robinson DR et al. Personalized oncology through integrative high-throughput sequencing: a pilot study. Sci. Transl. Med.3(111), 111–121 (2011).
- Chen R, Mias GI, Li-Pook-Than J et al. Personal omics profiling reveals dynamic molecular and medical phenotypes. Cell148, 1293–1307 (2012).
- Dennis C. The rise of the ‘narciss-ome’. Nature doi:10.1038/nature.10240 (2012) (Epub ahead of print).
- Roukos DH. Spatiotemporal individual genome code–lifestyle network: revolutionizing personal diagnostics. Expert Rev. Mol. Diagn.12(3), 215–218 (2012).
- Roukos DH. Longevity with systems medicine? Epigenome, genome and environment interactions network. Epigenomics4(2), 119–123 (2012).
- Roukos DH, Katsios C, Liakakos T. Genotype–phenotype map and molecular networks: a promising solution in overcoming colorectal cancer resistance to targeted treatment. Expert Rev. Mol. Diagn.10(5), 541–545 (2010).
- Katsios C, Roukos DH. Individual genomes and personalized medicine: life diversity and complexity. Per. Med.7(4), 347–350 (2010).
- Marshall E. Human genome 10th anniversary. Waiting for the revolution. Science331(6017), 526–529 (2011).
- Roy S, Ernst J, Kharchenko PV et al.; modENCODE Consortium. Identification of functional elements and regulatory circuits by Drosophila modENCODE. Science330(6012), 1787–1797 (2010).
- Ideker T, Krogan NJ. Differential network biology. Mol. Syst. Biol.8, 565 (2012).
- Baylin SB, Jones PA. A decade of exploring the cancer epigenome – biological and translational implications. Nat. Rev. Cancer.11(10), 726–734 (2011).
- Bisson N, James DA, Ivosev G et al. Selected reaction monitoring mass spectrometry reveals the dynamics of signaling through the GRB2 adaptor. Nat. Biotechnol29, 653–658 (2011).
- Welch CM, Elliott H, Danuser G, Hahn KM. Imaging the coordination of multiple signalling activities in living cells. Nat. Rev. Mol. Cell. Biol.12(11), 749–756 (2011).
- Fabbro D, Cowan-Jacob SW, Möbitz H, Martiny-Baron G. Targeting cancer with small-molecular-weight kinase inhibitors. Methods Mol. Biol.795, 1–34 (2012).
- Roukos DH. Complete genome sequencing and network modeling to overcome trastuzumab resistance. Pharmacogenomics11, 1039–1043 (2010).
- Yachida S, Jones S, Bozic I et al. Distant metastasis occurs late during the genetic evolution of pancreatic cancer. Nature467(7319), 1114–1117 (2010).
- Snyder M, Du J, Gerstein M. Personal genome sequencing: current approaches and challenges. Genes Dev.24, 423–431 (2010).
- Ashley EA, Butte AJ, Wheeler MT et al. Clinical assessment incorporating a personal genome. Lancet375, 1525–1535 (2010).
- Ross-Innes CS, Stark R, Teschendorff AE et al. Differential oestrogen receptor binding is associated with clinical outcome in breast cancer. Nature481(7381), 389–393 (2012).